Copyright
©The Author(s) 2021.
World J Clin Cases. Apr 26, 2021; 9(12): 2739-2750
Published online Apr 26, 2021. doi: 10.12998/wjcc.v9.i12.2739
Published online Apr 26, 2021. doi: 10.12998/wjcc.v9.i12.2739
Table 2 Summary of immunohistochemical results for four cases of superficial CD34-positive fibroblastoma
| Marker | CD34 | CK | SMA | EMA | S100 | HMB45 | MDM-2 | CDK-4 | ALK | STAT-6 | p53 | CD99 | CD68 | Des | Ki-67 |
| Case 1 | + | -/+ | - | - | - | - | - | - | - | - | - | - | - | - | 1% |
| Case 2 | + | - | - | - | - | - | - | - | - | - | - | ± | - | - | 2% |
| Case 3 | + | -/+ | - | - | - | - | - | - | - | - | - | - | - | - | 5% |
| Case 4 | + | - | - | - | - | - | - | - | - | - | - | - | - | - | 2% |
- Citation: Ding L, Xu WJ, Tao XY, Zhang L, Cai ZG. Clinicopathological features of superficial CD34-positive fibroblastic tumor. World J Clin Cases 2021; 9(12): 2739-2750
- URL: https://www.wjgnet.com/2307-8960/full/v9/i12/2739.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i12.2739